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Genetic studies in the mouse have implicated ephrin-B2 (encoded by the gene Efnb2) in blood vessel formation, cardiac development and
remodeling of the lymphatic vasculature. Here we report that loss of ephrin-B2 leads to defects in populations of cranial and trunk neural crest
cells (NCC) and to defective somite development. In addition, we show that Efnb1/Efnb2 double heterozygous embryos exhibit phenotypes in a
number of NCC derivatives. Expression of one copy of a mutant version of Efnb2 that lacks tyrosine phosphorylation sites was sufficient to rescue
the embryonic phenotypes associated with loss of Efnb2. Our results uncover an important role for ephrin-B2 in NCC and somites during
embryogenesis and suggest that ephrin-B2 exerts many of its embryonic function via activation of forward signaling.
© 2007 Elsevier Inc. All rights reserved.Keywords: Neural crest cells; Somites; Ephrin; SignalingIntroduction
Eph receptors and ephrins are cell surface signaling proteins
that were first identified for their role in axon guidance in
vertebrates, and which have been shown subsequently to
regulate a number of developmental processes in vertebrates
and invertebrates. Moreover, there is growing evidence that
these proteins also function in the adult, both in pathological
and physiological situations (Pasquale, 2005; Poliakov et al.,
2004; Surawska et al., 2004). At the cellular level, Eph receptors
and ephrins control cell migration and cell sorting as well as gap
junction communication (Davy et al., 2006). Eph and ephrins
have a unique bidirectional mode of action in which both
receptors and ligands can activate downstream signaling
cascades (Bruckner et al., 1997; Davy et al., 1999; Holland et
al., 1996). The signaling cascade activated downstream of Eph
receptors is referred to as forward signaling while the signaling
cascade activated downstream of ephrins is known as reverse
signaling. A number of studies using various model systems⁎ Corresponding author. Fax: +1 206 667 6522.
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doi:10.1016/j.ydbio.2006.12.028have suggested that both forward and reverse signaling cascades
are required in vivo (Davy and Soriano, 2005).
There are two structurally distinct classes of ephrins:
ephrins-A (A1 to A6) are tethered to the plasma membrane
via a glycosylphosphoinositide (GPI) tail whereas ephrins-B
(B1 to B3) are transmembrane proteins. At the protein level,
ephrin-B1 and ephrin-B2 share a high degree of identity, while
the third member of the ephrin-B family, ephrin-B3, is more
distantly related. Although some of the proximal events
contributing to the signal transduction cascade activated
ephrins-B have been identified (Murai and Pasquale, 2003),
the exact molecular mechanisms by which reverse signaling is
achieved remain elusive. The cytoplasmic tail of transmem-
brane ephrins contains two distinct signaling domains: a stretch
of tyrosines that are phosphorylated in response to Eph receptor
binding and a PDZ-binding domain that allows for interaction
with various PDZ-containing proteins. Eph/ephrin interaction
induces a Src-dependent tyrosine phosphorylation of the
cytoplasmic tail of ephrins-B leading to the recruitment of
Grb-4 and the tyrosine phosphatase PTP-BL (Cowan and
Henkemeyer, 2001; Palmer et al., 2002). It has been shown
recently that Eph-induced activation of Src-family kinases
involves processing of ephrins-B by PS1/γsecretase (Georga-
kopoulos et al., 2006). Unlike Grb-4, the interaction between
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dent of Eph/ephrin binding. A number of PDZ-containing
proteins have been shown to interact with ephrins-B (Lin et al.,
1999), some of which contribute to reverse signaling (Lu et al.,
2001). The importance of the PDZ-binding domain for the in
vivo function of ephrins-B has been recently demonstrated in
the mouse. Elimination of the PDZ-binding domain of ephrin-
B1 recapitulated some of the craniofacial phenotypes asso-
ciated with loss of ephrin-B1 (Davy et al., 2004) and a similar
mutation in ephrin-B2 led to lymphatic defects (Makinen et al.,
2005). On the other hand, the in vivo relevance of tyrosine
phosphorylation of ephrins-B has yet to be proven, since
expression of a mutant form of ephrin-B2 that could not be
phosphorylated yielded only minor phenotypes (Makinen et al.,
2005).
The phosphorylatable tyrosines as well as the PDZ-binding
domain are located in a carboxy-terminal 33-amino acid stretch
that is 100% identical in all 3 ephrins-B indicating that these
proteins might activate indistinguishable signaling cascades. In
addition, ephrin-B1 and ephrin-B2 can bind a similar set of Eph
receptors (although ephrin-B2 has a higher affinity for Eph-B4
and ephrin-B1 does not appear to bind Eph-A4) and Efnb1 and
Efnb2 are co-expressed in a number of tissues and cells during
early mouse embryonic development including endothelial
cells, epithelial somites, neural tube and branchial arches. All of
these observations raise the possibility that ephrin-B1 and
ephrin-B2 might be functionally redundant and might compen-
sate for each other during embryonic development. Redundancy
has been described for Eph receptors and GPI-linked ephrins
previously (for instance see (Feldheim et al., 2000; Orioli et al.,
1996). On the other hand, the fact that Efnb1 and Efnb2 null
mice exhibit profoundly distinct phenotypes (Adams et al.,
1998; Compagni et al., 2003; Davy et al., 2004; Wang et al.,
1998) argues that these proteins have specific, non-redundant
functions.
Studies in zebrafish, Xenopus and chick embryos have
implicated Eph/ephrins in neural crest cell (NCC) migration. In
the chick, Efnb1 is expressed in the posterior half of the somites
and disruption of Eph/ephrin interaction led to trunk NCC
migration defects (Krull et al., 1997). In Xenopus, EphA4/
EphB1 receptors and Efnb2 are expressed in adjacent domains
in the hindbrain region and inhibition of EphA4/EphB1
function led to abnormal NCC migration (Smith et al., 1997).
In the mouse, Efnb2 expression is restricted to the posterior half
of the somites and in vitro, Eph-expressing NCC avoided
ephrin-containing stripes (Wang and Anderson, 1997) suggest-
ing that ephrin-B2 acts as a repulsive cue for trunk NCC.
Surprisingly, no trunk NCC migration defects have been
reported to date in Efnb2 or Efnb1 deficient mice (Adams et al.,
1998; Compagni et al., 2003; Davy et al., 2004; Wang et al.,
1998).
To better assess the role of ephrin-B2 signaling in NCC in the
mouse, we have generated Efnb2 null or tyrosine phosphorylation
mutant mouse lines as well as Efnb1/Efnb2 double heterozygous
mutant mice. We found that Efnb2 null embryos exhibited trunk
NCC migration defects concomitant with somite defects. In
addition, we show that Efnb1/Efnb2 double heterozygous mutantembryos exhibited phenotypes in a number of NCC-derivatives
that were not previously known targets of Eph/ephrin signaling.
Expression of one copy of the phosphorylation mutant was
sufficient to rescue the defects associated with the loss of Efnb2.
Together these results uncover novel roles for ephrin-B2 in NCC,
show that ephrin-B2 exerts most of its embryonic functions
independently of tyrosine phosphorylation and suggest that ephrin-
B1 and ephrin-B2 are functionally redundant in certain develop-
mental contexts.
Materials and methods
Mice
TheEfnb2GFP allele was generated by inserting the H2B-GFP cDNA cassette
at the MluI site in the first exon of the Efnb2 gene. The MluI–XbaI fragment
encompassing the start codon of the Efnb2 gene was replaced with the H2BGFP
cDNA. The Efnb2F5 allele was generated by fusing a partial cDNA (harboring Y
to F mutations) at the NcoI site in the first exon of Efnb2. The mutations were
introduced in ES cells by homologous recombination. Efnb2GFP and Efnb2F5
mice were maintained in 129S4/C57Bl6J and 129S4 congenic backgrounds,
respectively. Mice were housed in microisolator racks in a facility accredited by
the Association for the Assessment and Accreditation of Laboratory Animal
Care, and experimentation was reviewed by the Hutchinson Center Institutional
Review Committee. Genotyping was done by PCR using the following sets of
primers for the Efnb2GFP allele: GFP-F: 5′-GCAAGAAGGCGGTGACTAAG-
GCGC-3′; GFP-R: 5′-GGCCGCCGCCAGTGCTTGA GGTCG-3′. The
Efnb2F5 mouse line was genotyped with the following set of primers that am-
plifies both the mutant and wild type alleles: F5-F: 5′-CGGCTTGGGCAT-
GGCCATGGC-3′; F5-R1: 5′-AAGAGAAGGCTCGTGGACACC-3′; F5-R2:
5′-CTGAAATTCTAGACCCCAGAGG-3′.
Whole mount in situ hybridization
Embryos were fixed in 4% PFA overnight and subsequently dehydrated in
PBT (PBS/1%Tween)/methanol. Embryoswere stored in 100%methanol at 4 °C
until processed for in situ hybridization as described previously (Riddle et al.,
1993). Hybridization with DIG-labeled riboprobes was performed at 70 °C.
DIG-labeled riboprobes were detected with an AP-conjugated anti-DIG
antibody (Roche). BM purple (Roche) or NBT/BCIP (Roche) were used as a
substrate for the alkaline phosphatase. At least 3 embryos of each genotype were
used for each probe. We obtained the probe for Sox10 from Michael Wegner
(Kuhlbrodt et al., 1998), for Meox1 from Chris Wright, for Myogenin from
Norbert Kraut, for Sema3F from David Ginty and for Uncx4.1 from Peter
Gruss.
Whole mount immunohistochemistry
Neurofilament staining was performed on PFA-fixed embryos (n=3).
Briefly, embryos were dehydrated and rehydrated in methanol/PBT (PBS
containing 1% Tween 20) and incubated in blocking solution (PBS containing
1% BSA and 5% sheep serum) for 1 h at room temperature. Embryos were then
incubated overnight in primary antibody diluted 1:150 in blocking solution. The
2H3 anti-neurofilament antibody developed by Thomas M. Jessell and Jane
Dodd was obtained from the Developmental Studies Hybridoma Bank
developed under the auspices of the NICHD and maintained by the University
of Iowa, Department of Biological Sciences, Iowa City, IA 52242. Embryos
were washed extensively, blocked again and incubated overnight in secondary
antibody (1:75 dilution of HRP-conjugated anti-mouse from SIGMA). Next day,
the embryos were stained using the DAB kit (Vector Laboratories Inc.).
X-gal staining
X-gal staining was performed as previously described (Friedrich and
Soriano, 1993).
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H&E staining and sectioning was performed on paraffin embedded samples.
The size of the salivary gland was evaluated on photomicrographs of H&E
stained section using the PhotoShop software. Immunofluorescence was
performed on frozen sections using a monoclonal anti-ephrin-B1 antibody
(25H11, a kind gift from Wieland Huttner; Stuckmann et al., 2001). Briefly,
sections were incubated in blocking solution (PBS containing 5% horse serum)
for 1 h at room temperature and incubated with the 25H11 antibody (1:25)
overnight. Sections were then incubated with an anti-rat antibody conjugated to
Cy3.Results
Neural crest migration defects in Efnb2 null mice
We have generated a mouse line harboring a null mutation in
the Efnb2 gene by inserting a cDNA coding for a fusion protein
between histone 2B (H2B) and the green fluorescent protein
(GFP) in the first exon of the Efnb2 gene (Fig. 1). This
mutation places the expression of H2B-GFP under the control
of the Efnb2 promoter and creates a null allele for Efnb2
(referred to herein as Efnb2GFP). Loss of Efnb2 expression in
Efnb2GFP/GFP homozygous embryos was confirmed by RT-PCR
on RNA isolated from embryonic day (E) 10.5 embryos (Fig.
1B). Intercrosses between heterozygous parents failed to
produce any live homozygous offspring. Consistent with
previous observations (Wang et al., 1998; Adams et al., 1998),
homozygous embryos died at about E10.5 from cardiovascular
defects (Fig. 1C and data not shown). Analysis of whole
embryos at various stages of development revealed that nuclear
H2B-GFP was readily visible by epifluorescence and could be
used as a marker of ephrin-B2 expression in living embryos
(Fig. 1D). To confirm that the expression pattern of H2B-GFP
was similar to the documented expression pattern of Efnb2, we
examined tissues in which Efnb2 expression has been reported
previously such as blood vessels (Fig. 1Dd), branchial arches
(Fig. 1De), somites (Fig. 3), the nervous system and the retina
(data not shown). In all tissues examined the expression of H2B-
GFP was identical to the reported endogenous expression of
Efnb2. These results indicate that H2B-GFP can be used as a
bona fide marker for Efnb2 expression in mice carrying the
Efnb2GFP allele.
Using Sox10 as a marker of migrating NCC and the
combination of Wnt1Cre/R26R alleles for Cre recombinase-
based lineage tracking of NCC derivatives, we observed a
general reduction in the population of cranial NCC in Efnb2 null
embryos (Figs. 2Aa–d). The stream of NCC migrating toward
the second branchial arch (BA) was reduced in size, consistent
with a previous report (Adams et al., 2001). In addition we
observed a depletion of NCC migrating to the first BA (Figs.
2Ab, d). Consistent with the depletion of cranial NCC, the first
BA was often smaller and hypoplastic in Efnb2 null embryos
(Supplementary Fig. 1). In fact, 12/21 Efnb2GFP/GFP embryos
exhibited a severe reduction in the size of the first BA (Fig.
2Ad). Depletion of NCC was accompanied by an increase cell
death (assessed by Nile Blue staining) in the Efnb2GFP/GFP
embryos (data not shown). To test whether this phenotype wasspecific to NCC, we used an antibody specific for neurofilament
to label differentiating neurons. In Efnb2GFP/GFP embryos,
neurofilament staining showed a reduction in the fifth (tri-
geminal) cranial ganglion (a NCC derivative) but not in mid-
brain neurons (Figs. 2Ae, f). These results indicate that loss of
Efnb2 leads to a selective reduction in cranial NCC.
We also observed a disruption of trunk NCC migration in
our Efnb2 null embryos (Fig. 2B). In the Efnb2GFP/GFP
embryos, Sox10-positive trunk NCC detached from the main
migrating streams and migrated in a scattered fashion across
somites (Fig. 2Bb). In addition to this scattered migration, loss
of segmented migration of trunk NCC could be observed in the
most posterior part of Efnb2GFP/GFP embryos (Fig. 2Bd).
Histological sections showed that NCC invade the posterior
part of somites in Efnb2 mutant embryos (Fig. 2Bf). Trunk
NCC migration defects were observed in all of the Efnb2 null
embryos analyzed (n=11), however, the severity of the defects
was variable from embryo to embryo (data not shown).
Somite defects in Efnb2 null embryos
Ephrin-B2 is expressed in the posterior half of somites (Fig.
3) and therefore may control trunk NCC migration non-
autonomously, by acting as a repulsive cue for Eph-expressing
NCC. Alternatively, loss of ephrin-B2 could impair somite
development, which might in turn impinge on trunk NCC
migration. To better understand the underlying cause of the
trunk NCC migration defects observed in Efnb2 null embryos,
we analyzed somite development in these mutants. In the
absence of Efnb2, cells that normally express Efnb2 (GFP-
positive) were abnormally distributed across the somites (Figs.
3Aa, b) and clumping of GFP-positive cells could be observed
at the caudal boundary of somites (Fig. 3Ab). To analyze this
phenotype in more detail, we analyzed the distribution of GFP-
positive cells on sections of control and mutant embryos. In the
control embryo, epithelial cells expressing high levels of GFP
were distributed throughout the caudal half of somites (Figs.
3Ba–c). In Efnb2 null embryos the difference in the level of
GFP expression between the caudal and rostral half of somites
was attenuated (Figs. 3Bd–f). In addition, despite the fact that
epithelial cells expressing higher levels of GFP were found
close to the caudal boundary, these cells were clustered at the
medial edge of the somites and did not extend laterally (Figs.
3Bd–f). These observations indicate that loss of Efnb2 might
affect the patterning of somites. To test for this we monitored the
expression of a number of markers of somite polarity. At 20–22
somite stage, the expression of Uncx4.1, a marker of the caudal
compartment appeared polarized in Efnb2GFP/GFP embryos,
however, the level of expression was decreased as compared to
control embryos and the boundary between the expressing and
non-expressing domain was not as sharp as in the control
embryos (Figs. 3Ca, b). The reduction in Uncx4.1 expression
levels was already evident at the 10 somite stage (Supplemen-
tary Fig. 2). The expression level of Meox1, another marker of
the caudal compartment, was also diminished in Efnb2 null
embryos (Figs. 3Cc, d), consistent with a loss of caudal
properties in somites. However, the decrease in the expression
Fig. 1. Generation of an Efnb2 null mouse line. (A) Efnb2 wild type locus (a), targeting vector (b) and targeted locus (c). (B) Left: Southern blot analysis of ES clones
showing a wild type clone (+/+) and a targeted clone (+/GFP) that was used for blastocyst injection. The probe is indicated in grey in Aa. Right: RT–PCR analysis on
RNA isolated from E10.5 embryos of various genotypes, as indicated. Efnb2 expression is absent in Efnb2GFP/GFP embryos. Expression of β-actin is used as a control.
(C) Epifluorescence images of E10.5 embryos showing expression of H2B-GFP in Efnb2+/GFP embryos (a) and Efnb2GFP/GFP embryos (b). (D) Epifluorescence
images of Efnb2+/GFP embryos at E9.5 (a, d, e), E12.5 (b) and E14.5 (c). Expression of H2B-GFP in endothelial cells (d) epithelial lining of branchial arches (e).
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panied by an expansion of the rostral compartment since Tbx18,
a gene expressed anteriorly in somites, appeared identical in
control and Efnb2 null embryos (data not shown). These results
indicate that loss of Efnb2 perturbs the patterning of somites.
Sema3F, which is expressed in somites, has recently been
implicated in regulating the migration of trunk NCC (Gammill
et al., 2006). At the 19–20 somite stage, Sema3F was expressedin the posterior part of somites in control embryos (Fig. 3Ce),
however, the polarized expression of Sema3F was completely
lost in Efnb2 null embryos (Fig. 3Cf). To rule out the possibility
that the phenotypic differences in the mutant embryos were
secondary to developmental delays associated with angiogenic
defects, we examined the expression of this marker at an earlier
stage of development. The loss of polarized Sema3F expression
was already evident at the 14 somite stage, even though mutant
Fig. 2. Neural crest cell defects in Efnb2 null embryos. (A) Efnb2+/GFP embryos (a, c, e) and Efnb2GFP/GFP embryos (b, d, f ) were stained with the following markers:
Sox10 (a, b), Wnt1Cre/R26R (c, d) and neurofilament (e, f ). A decrease in the cranial NCC population migrating to the first (arrow) and second (arrowhead) BA is
visible and all markers show a reduced size of the fifth cranial ganglion (asterisk) in Efnb2 null embryos. (B) Efnb2+/GFP embryos (a, c) and Efnb2GFP/GFP embryos
(b, d) were stained with the following markers: Sox10 (a, b) and Wnt1Cre/R26R (c, d). Scattered migration of trunk NCC can be seen in Efnb2 homozygous null
embryos, as well as loss of segmented migration (brackets). Histological sections of X-gal-stained control (e) and Efnb2mutant (f ) embryos show that NCC invade the
posterior (P) half of somites in mutant embryos. In control embryos, NCC migration is restricted to the anterior (A) half of somites. The black lines mark somite
boundaries based on the position of the dermomyotome.
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(Figs. 3Cg, h). This data shows that loss of Efnb2 perturbs the
distribution of Sema3F in somites.
To test whether the changes in polarity markers observed in
Efnb2GFP/GFP embryos were concomitant with impaired somite
differentiation, we analyzed the expression of Myogenin (a
marker of myogenic differentiation) and Twist (a marker ofepithelial somites that later becomes restricted to the sclerotome
and dermatome). At the 26-somite stage, the expression pattern
of Twist indicated that the somites were less mature in the
mutant embryos (Figs. 4a, b). Consistent with this, the
expression of Myogenin was barely detectable in Efnb2 null
embryos at the 26-somite stage (Figs. 4c, d). Myogenin
expression was already delayed in Efnb2GFP/GFP at the 18-
Fig. 3. Somite defects in Efnb2 null embryos. (A) Epifluorescence images of Efnb2+/GFP embryos (a) and Efnb2GFP/GFP embryos (b) showing that the somitic
distribution of GFP-positive cells of Efnb2 null embryos is disrupted. (B) Dorsal view of sections of Efnb2+/GFP (a–c) and Efnb2GFP/GFP embryos (d–f ). Actin
staining (a, d) and Efnb2 expression (b, e) show that cells expressing higher levels of GFP are abnormally clustered at the medial edge of somites in mutant embryos.
The mesoderm (m) visible laterally in the pictures of Efnb2 null embryo (d–f ) is due to an incomplete closure of the body wall. m: mesoderm; nt: neural tube; s:
somite. (C) Expression of Uncx4.1, Meox1 and Sema3F was detected by in situ hybridization on control embryos (a, c, e) and Efnb2GFP/GFP embryos (b, d, f ).
Expression of uncx4.1 is decreased and diffused, while polarized expression ofMeox1 and Sema3F is lost in mutant embryos. So: Somite numbers indicated for both
control (highest number) and mutant (lowest number) embryos. One number indicates that both control and mutant embryos had the same number of somites. Anterior
(A) is to the right and posterior (P) is to the left in all pictures shown.
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Fig. 5. Generation of Efnb2F5 mice. (A) Efnb2 wild type locus (a), targeting
vector (b) and targeted locus (c). (B) Epifluorescence images of Efnb2F5/GFP (a)
and Efnb2GFP/GFP (b) embryos.
Fig. 4. Delayed somite differentiation in Efnb2mutants. (A) Expression of Twist
(a, b) andMyogenin (c–f ) in wild type (a, c, e) and Efnb2GFP/GFP embryos (b, d,
f ) show that somite differentiation is impaired in Efnb2 null embryos. so:
Somite numbers.
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similar number of somites (Figs. 4e, f ), indicating that these
phenotypes are not secondary to the developmental delay
caused by the defective angiogenesis. These results indicate that
loss of Efnb2 perturbs somite patterning and impairs somite
differentiation.
Tyrosine phosphorylation of ephrin-B2 is not required for NCC
migration
To ask whether tyrosine phosphorylation was required for
the function of ephrin-B2 in somite patterning and NCC
development, we generated a mouse line expressing a mutant
form of ephrin-B2 in which all of the tyrosine residues were
mutated to phenylalanine, therefore preventing tyrosine
phosphorylation of ephrin-B2 (Fig. 5A). As a control for the
targeting strategy, we also created a mouse line carrying a wild
type ephrin-B2 cDNA that showed no developmental pheno-
types (data not shown). Genotyping of 10-day-old pups showed
that Efnb2F5/F5 homozygous animals were recovered at the
expected Mendelian ratio (Table 1). In addition, one copy of
the Efnb2F5 allele was sufficient to rescue the developmentaldefects associated with the loss of Efnb2, since Efnb2F5/GFP
were completely viable and fertile (Fig. 5B and Table 1). These
mutants did not present craniofacial defects and exhibited
normal development of the axial skeleton, suggesting that
tyrosine phosphorylation of ephrin-B2 is dispensable for
somite patterning and NCC development. However, these
results could also indicate that ephrin-B1 might compensate for
the loss of ephrin-B2 reverse signaling in tissues where both
ephrins are expressed, such as endothelial cells, somites and
NCCs. To test for this possibility, we mated Efnb2F5/F5 mice
with Efnb1Y/− mice (Davy et al., 2004) to generate double
mutants. As a control, we also crossed Efnb2+/GFP mice with
Efnb1 mutants. Removing one copy of Efnb2 in an Efnb1
mutant background led to phenotypes that were not observed in
Efnb1 single mutants (Table 2 and Fig. 6), indicating that
Efnb1 and Efnb2 interact genetically. In contrast, Efnb2F5/F5
mutant mice lacking Efnb1 only exhibited the phenotypes
associated with the loss of Efnb1 (Table 2 and data not shown).
These results show that the lack of embryonic phenotype in
Efnb2F5/F5 mice is not due to functional compensation by
ephrin-B1.
Redundancy between ephrin-B1 and ephrin-B2 in NCC
derivatives
To better characterize the genetic interaction between
Efnb1 and Efnb2, we further analyzed the Efnb1/Efnb2
double heterozygous embryos. Although ephrin-B1 hetero-
zygous females display phenotypes not observed in homo-
zygous females or hemizygous males due to X-inactivation
and subsequent sorting of ephrin-B1 expressing and non-
expressing cells (Compagni et al., 2003; Davy et al., 2004),
Table 1
Efnb2F5 homozygous and hemizygous embryos are viable
Genotypes Efnb2+/F5×Efnb2+/F5 Efnb2+/F5×Efnb2+/GFP
Efnb2+/+ Efnb2+/F5 Efnb2F5/F5 Efnb2+/+ Efnb2+/F5 Efnb2+/GFP Efnb2F5/GFP
Ratio (number) 22% (28) 50% (62) 28% (36) 18.0% (11) 37.9% (22) 22.5% (13) 20.7% (12)
The ratio for each genotype is indicated as a percentage. The total number of pups of each genotypes is also presented.
Table 2
Genetic interaction between Efnb1 and Efnb2
Genotypes Efnb2F5/F5×Efnb2+/F5; Efnb1+/−
B2+/F5/B1+/+ B2+/F5/B1Y/− B2F5/F5/B1+/+ B2F5/F5/B1Y/−
Ratio (number) 38% (23) 19.5% (12) 23% (14) 19.5% (12)
Genotypes Efnb2+/GFP×Efnb1+/−
B2+/+/B1+/+ B2+/+/B1Y/− B2+/GFP/B1+/+ B2+/GFP/B1Y/−
Ratio (number) 35% (19) 22% (12) 43% (23) – (0)
The ratio for each genotype is indicated as a percentage. The total number of pups
of each genotypes is also presented. For clarity, Efnb1Y/− males and Efnb1+/−
females have been grouped under the genotype Efnb1Y/−, since they have similar
phenotypes. Efnb2F5/F5/Efnb1Y/− mice are viable while Efnb2+/GFP/Efnb1Y/− die
perinatally.
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Efnb1Y/−/Efnb2+/GFP males and Efnb1+/−/Efnb2+/GFP females
(double mutants are henceforth referred to as Efnb1/Efnb2
mutants). While Efnb1/Efnb2 mutant embryos exhibited
normal trunk NCC migration and somite development
(Supplementary Fig. 3A), they presented defects in a number
of tissues that have not previously been known to require
EphB/ephrinB signaling including the salivary gland and the
dermis (Fig. 6), and the cartilage of the trachea (Supplemen-
tary Figs. 2c, d). In 3/3 Efnb1/Efnb2 mutant embryos the
salivary gland was ∼40% smaller and less mature than in
control embryos (Fig. 6A and Supplementary Fig. 3B).
Cultures of wild type and Efnb1/Efnb2 mutant salivary glands
indicated that the branching morphogenesis defect is rescued
in vitro (data not shown), indicating that the phenotype
observed in vivo could be due to defective growth factor
signaling. Failure to close the eyelids during late embryogen-
esis was observed in 11/13 Efnb1/Efnb2 embryos (Fig. 6B).
While ephrin-B1 is expressed in the dermis (Fig. 6Ca),
ephrin-B2 is normally expressed in the epidermis (Fig. 6Cb).
Interestingly, expression of ephrin-B2 is up-regulated in the
dermis of the growing eyelids (Fig. 6Cc). Lineage tracing
using Wnt1Cre/R26R alleles showed that the dermis of the
eyelids is derived from NCC (Fig. 6Cd). Similarly, Efnb1 and
Efnb2 were found to be co-expressed in the NCC-derived
mesenchyme of the salivary gland (data not shown). These
results demonstrate that ephrin-B1 and ephrin-B2 are co-
expressed in mesenchymal cells of neural crest origin and
suggest that they exert redundant functions in these cells.
Discussion
Ephrin-B2 in cranial NCC
In this paper we document that Efnb2 is required for NCC
development. We observed a number of defects in cranial NCC
in Efnb2 null embryos. Streams of migrating NCC to the first
and second BA were reduced, possibly due to cell death. As a
consequence of this depletion of cranial NCC, the first BAwas
small and hypoplastic while formation of the fifth ganglion was
impaired. Interestingly, expression of Sema3F appeared
unchanged in the cranial region of Efnb2 null embryos (data
not shown). In addition to this early function of Efnb2 in cranial
NCC, we have also uncovered a role for Efnb2 in cranial NCC-
derivatives by generating and analyzing Efnb1/Efnb2 double
mutants. Although we have shown previously that loss of Efnb1
leads to craniofacial defects (Davy et al., 2004), the Efnb1/
Efnb2 double mutants exhibited additional phenotypes thatwere not observed in Efnb1 single mutants. The Efnb1/Efnb2
mutants were born with an open eye phenotype which is usually
linked to an epidermal migration defect (Xia and Kao, 2004). In
the developing embryo, ephrin-B1 and ephrin-B2 were co-
expressed in the dermis at the leading edge of the eyelids,
suggesting that ephrin-B1 and ephrin-B2 might perform
redundant function to regulate epidermal migration non-
autonomously. We have also noted a delay in growth and
maturation of the salivary gland in Efnb1/Efnb2 embryos. In the
double mutants, the gland was smaller, less branched and EGF
production was decreased. Since ephrin-B1 and ephrin-B2 are
expressed in the mesenchyme in the gland while EphB2 is
expressed in the epithelium (J. Bush and P.S., unpublished
observation), an attractive possibility is that ephrin-B1 and
ephrin-B2 regulate epithelial branching in the salivary gland
non-autonomously by activating forward signaling. Interest-
ingly, involvement of EphA/ephrinA signaling in regulating
growth factor-induced branching morphogenesis has been
reported previously (Miao et al., 2003).
Ephrin-B2 regulates trunk NCC migration
In the trunk, we observed the disruption of segmented
migration of trunk NCC. However, segmented migration was
not lost entirely, possibly reflecting the fact that other molecules
are involved in controlling this process, including other Eph/
ephrins (McLennan and Krull, 2002), as well as other guidance
molecules such as semaphorins/neuropilins (Gammill et al.,
2006; Kawasaki et al., 2002) and Slit/ROBO (Jia et al., 2005).
The fact that this phenotype was not reported previously
(Adams et al., 1998; Wang et al., 1998) might be due to the use
of more sensitive markers than available previously, including
Fig. 6. Phenotypes in Efnb1/Efnb2 double mutant embryos. (A) H&E staining of salivary glands from E15.5 embryos shows that salivary gland from Efnb1+/−/Efnb2+/GFP
double mutant (c) is smaller than either wild type (a) or Efnb1+/− single mutant (b) salivary glands. (B) Efnb1+/−/Efnb2+/GFP double heterozygous E18.5 embryos (b, d)
exhibit an “open eye” phenotype. Eyelids are fused in E18.5 control embryos (a, c). (C) Immunofluorescent staining of ephrin-B1 (a) and epifluorescent image of H2B-GFP
(b, c) show that ephrin-B1 is expressed in the dermis (D) while ephrin-B2 is most highly expressed in the epidermis (E) in the developing embryo. Ephrin-B2 expression is
upregulated at the tip of the eyelids (asterisk in c). Paraffin section of a X-gal-stained E14.5 embryo carrying the Wnt1Cre/R26R alleles showing that the dermis of the
growing eyelids (arrows) is derived from NCC (d).
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2000; Jiang et al., 2002). The defect in trunk NCC migration
observed in Efnb2 null embryos is consistent with previous
studies in the chick and the mouse that had proposed that
transmembrane ephrins act as repulsive cues for migrating NCC
expressing Eph receptors (Krull et al., 1997; Wang and
Anderson, 1997). Our observations are also consistent with
previous work showing that disruption of segmented NCC
migration in Delta-1 null mice correlated with loss ofexpression of Efnb2 in the posterior part of somites (De Bellard
et al., 2002). Here we show that loss of Efnb2 perturbs the
distribution of Sema3F. Interestingly, Sema3F has been shown
recently to act as a repulsive cue for migrating trunk NCC in the
mouse (Gammill et al., 2006) and it has been shown in zebrafish
embryos that aberrant expression of class-3 semaphorins leads
to abnormal cranial NCC migration (Yu and Moens, 2005).
Thus, one possibility is that mislocalization of Sema3F leads to
the trunk NCC migration defects in Efnb2 null embryos.
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defects reported in the Sema3F null embryos were more severe
than the defects we observed in Efnb2 null embryos (Gammill
et al., 2006). Alternatively, it is also possible that multiple
pathways cooperate in guiding trunk NCCs, perhaps by
converging on the regulation of common cellular targets.
Recent work has indeed shown that semaphorin signaling can
regulate integrins, which are also a target of ephrins (Kruger
et al., 2005; Nakamoto et al., 2004). Based on these results,
we propose that in addition to directly regulating the migration
of trunk NCCs via repulsion (Krull et al., 1997; Wang and
Anderson, 1997), ephrin-B2 also regulates the migration of
trunk NCCs by controlling the expression of somitic genes.
Somite defects in Efnb2 null embryos
In absence of Efnb2, both somitic polarity and somitic
differentiation markers were perturbed. To date, the impor-
tance of Eph/ephrins signaling in somitogenesis has been most
strongly established in zebrafish. Perturbation of Eph/ephrin
signaling by overexpression of dominant negative forms of
Eph and ephrins in zebrafish leads to severe segmentation
defects and reduced or disturbed MyoD expression (Durbin et
al., 1998). Abnormal expression of several ephrins and Eph
receptors has also been shown to correlate with somite
segmentation defects in the fss (fused somites) zebrafish
mutant. In this mutant, restoration of Eph/ephrin signaling was
sufficient to rescue most aspects of boundary formation
(Barrios et al., 2003; Durbin et al., 2000). Finally, it has
been shown recently that integrin/fibronectin and Eph/ephrin
systems function cooperatively in maintaining somite bound-
aries in zebrafish embryos (Koshida et al., 2005). Our results
indicate that in the mouse, somite segmentation often proceeds
normally in absence of Efnb2, although we have obtained a
few embryos exhibiting abnormal somite morphology. These
results are consistent with the fact that no defects in somite
development have been reported in EphA4 null mice (EphA4
binds to ephrin-B2 and is expressed in the rostral compartment
of somites). Interestingly, it has been reported recently that
forced expression of the transcription factor Mesp2 in somitic
cells in mouse embryos leads to the activation of EphA4 and
the repression of Uncx4.1 (Nakajima et al., 2006), consistent
with what we have observed in Efnb2 null embryos. The fact
that somite segmentation proceeds normally in absence of
Efnb2 or EphA4 raises the possibility that other members of
the Eph receptor or ephrin family might compensate for the
loss of either gene. No somite defects were observed in either
Efnb1 null embryos (data not shown) or Efnb1/Efnb2 double
heterozygous mutant embryos indicating that ephrin-B1 is not
required for somite formation and that one copy of Efnb2 is
sufficient for normal somite development, even in absence of
Efnb1. However, it would be interesting to analyze somite
development in the mouse, in the conditional absence of both
Efnb1 and Efnb2 in somitic cells. Similarly, the analysis of
conditional EphA4/Efnb2 double null embryos might further
our understanding of the role of these proteins in somite
development.Ephrin-B2 reverse signaling in mouse development
A number of genetic studies in the mouse have addressed
the question of ephrin-B2 reverse signaling in vivo. Adams
et al. showed that a mutant version of ephrin-B2 lacking the
cytoplasmic tail was able to rescue a cranial NCC migration
defect but not the cardiovascular defect that are observed in
Efnb2 null embryos. From these results the authors concluded
that ephrin-B2 reverse signaling was essential for angiogen-
esis but not for cranial NCC migration (Adams et al., 2001).
This conclusion was challenged later on with the generation
of a mouse line in which the cytoplasmic tail of ephrin-B2
was removed and replaced by β-galactosidase. Embryos
carrying this allele were born alive but died shortly after birth
presumably because of cardiac malformations (Cowan et al.,
2004). These data indicated that the cytoplasmic tail of
ephrin-B2 and therefore reverse signaling was not required for
angiogenesis, but was important for cardiac valve formation.
More recently, point mutations have been introduced in the
cytoplasmic tail of ephrin-B2 that either disrupt interactions
with PDZ-containing proteins or abolish tyrosine phosphor-
ylation. These studies have revealed a post-natal role for the
PDZ-binding domain of ephrin-B2 since mice homozygous
for the ephrinB2ΔV mutation were born alive but died
prematurely because of defects in remodeling of the lymph
vasculature (Makinen et al., 2005). On the other hand, mice
expressing a mutant version of ephrin-B2 that cannot be
tyrosine-phosphorylated (ephrinB25Y) survived until adult-
hood and presented mild defects in the lymph vasculature that
could be due to the fact that the PDZ-binding domain might
have been disrupted in this allele (Makinen et al., 2006).
Taken together, these results are consistent with the notion
that ephrin-B2 reverse signaling is not required for early
vascular development.
We found that all of the phenotypes associated with loss of
Efnb2, including the loss of cranial NCCs and the defective
patterning of somites could be rescued by expression of a
mutant form of ephrin-B2 that cannot be tyrosine-phosphory-
lated, indicating that tyrosine phosphorylation of ephrin-B2 is
not essential for embryonic development. Because ephrin-B1
and ephrin-B2 are co-expressed in many cell types and tissues,
one possible explanation for the lack of embryonic phenotype in
the Efnb2F5/F5 mice was functional compensation. The results
presented in this manuscript indicate that this is not the case
since eliminating Efnb1 in Efnb2F5/F5 background did not
uncover embryonic phenotypes. On the other hand, Efnb1/
Efnb2 double heterozygotes exhibited phenotypes that had not
been observed in Efnb1 single mutants, indicating that Efnb1
and Efnb2 interact genetically.
In conclusion, our results show that in addition to its role in
angiogenesis, ephrin-B2 also plays an important role in NCC
and somite development during mammalian embryogenesis.
Remarkably, we provide evidence that these functions are
tyrosine phosphorylation–independent. These results, com-
bined with other studies in the mouse (Makinen et al., 2005),
suggest that ephrin-B2 acts primarily as a ligand to activate
Eph-induced forward signaling during early embryogenesis.
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